Metropolitan Life Insurance Company (MetLife)’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,160
| Closed | -$17.4K | – | 2463 |
|
|
2022
Q1 | $17.4K | Sell |
3,160
-9,199
| -74% | -$50.7K | ﹤0.01% | 2147 |
|
|
2021
Q4 | $120K | Sell |
12,359
-469
| -4% | -$4.54K | ﹤0.01% | 2370 |
|
|
2021
Q3 | $229K | Hold |
12,828
| – | – | ﹤0.01% | 1967 |
|
|
2021
Q2 | $313K | Buy |
12,828
+2,620
| +26% | +$64K | ﹤0.01% | 1830 |
|
|
2021
Q1 | $271K | Buy |
+10,208
| New | +$271K | ﹤0.01% | 1807 |
|
|
2020
Q3 | – | Sell |
-12,114
| Closed | -$72.4K | – | 2602 |
|
|
2020
Q2 | $72.4K | Buy |
+12,114
| New | +$72.4K | ﹤0.01% | 2425 |
|
|
2020
Q1 | – | Sell |
-10,653
| Closed | -$101K | – | 2567 |
|
|
2019
Q4 | $101K | Sell |
10,653
-1,214
| -10% | -$11.5K | ﹤0.01% | 2326 |
|
|
2019
Q3 | $93.2K | Hold |
11,867
| – | – | ﹤0.01% | 2339 |
|
|
2019
Q2 | $187K | Hold |
11,867
| – | – | ﹤0.01% | 1930 |
|
|
2019
Q1 | $215K | Buy |
11,867
+4,676
| +65% | +$84.6K | ﹤0.01% | 1863 |
|
|
2018
Q4 | $116K | Sell |
7,191
-618
| -8% | -$9.94K | ﹤0.01% | 2173 |
|
|
2018
Q3 | $187K | Buy |
+7,809
| New | +$187K | ﹤0.01% | 2048 |
|